TREM2 R47H and ABI3 rs616338 are both AD risk loci linked to microglial response, phagocytosis, and cytoskeletal remodeling. The notebook prioritizes them as a convergent module rather than isolated targets. Hypothesis: restoring TREM2-dependent lipid sensing together with ABI3-linked actin remodeling will rescue plaque engagement and debris clearance more robustly than modulating either locus alone in human iPSC-microglia.
Specific butyrate-producing gut bacteria (e.g., Faecalibacterium, Roseburia) generate systemic butyrate that crosses the blood-brain barrier and inhibits hippocampal microglial HDAC2, leading to hyperacetylation of transcription factors that upregulate TREM2-independent phagocytic pathways. This enhances microglial amyloid-beta uptake and lysosomal degradation while suppressing NLRP3 inflammasome activation. Testable prediction: Germ-free AD mice colonized with butyrate-producing bacteria or tre
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
7/11
dimensions won
TREM2-ABI3 actin-phagocytosis coupling i
4/11
dimensions won
Gut-derived butyrate reprograms microgli
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.68
0.00
Evidence
0.62
0.72
Novelty
0.61
0.68
Feasibility
0.57
0.78
Impact
0.70
0.00
Druggability
0.62
0.00
Safety
0.52
0.00
Competition
0.00
0.00
Data
0.75
0.00
Reproducible
0.60
0.00
KG Connect
0.50
0.50
Score Breakdown
Dimension
TREM2-ABI3 actin-phagocytosis
Gut-derived butyrate reprogram
Mechanistic
0.680
0.000
Evidence
0.620
0.720
Novelty
0.610
0.680
Feasibility
0.570
0.780
Impact
0.700
0.000
Druggability
0.620
0.000
Safety
0.520
0.000
Competition
0.000
0.000
Data
0.750
0.000
Reproducible
0.600
0.000
KG Connect
0.500
0.500
Evidence
TREM2-ABI3 actin-phagocytosis coupling is a higher-yield AD
No evidence citations yet
Gut-derived butyrate reprograms microglia for amyloid cleara
No evidence citations yet
Debate Excerpts
Gut-derived butyrate reprograms microglia for amyl
4 rounds · quality: 0.95
Theorist
Based on the literature provided, I'll generate novel therapeutic hypotheses targeting the gut-brain axis for Alzheimer's disease prevention and treatment:
## Hypothesis 1: Microglial Priming Reset v...
Skeptic
I'll provide a rigorous critique of each hypothesis based on the provided literature and scientific principles.
## Hypothesis 1: Microglial Priming Reset via SCFA Epigenetic Modulation
**Critical We...
Domain Expert
I'll assess the practical feasibility of these gut-brain axis hypotheses for Alzheimer's disease, focusing on druggability, existing compounds, competitive landscape, and development timelines.
## OV...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Gut Barrier Reconstruction via Polysaccharide-Probiotic Synbiotics",
"description": "Rosa roxburghii polysaccharides combined with specif...